Domvanalimab (AB154) is an anti-TIGIT humanized monoclonal antibody. Domvanalimab binds human TIGIT9 and blocks the TIGIT-CD155 interaction. Domvanalimab can be used in research of cancer.
Purity:
>99.0%
CAS Number:
[2368219-35-4]
Target:
TIGIT
* VAT and and shipping costs not included. Errors and price changes excepted